Summary of Key Points Core Viewpoint - The announcement details the share reduction results of Suzhou Mediston Medical Technology Co., Ltd., specifically regarding shareholder Wang Jianhua's reduction of shares, which was executed as planned within the specified timeframe [2][3]. Group 1: Shareholder's Basic Situation - Before the reduction plan, shareholder Wang Jianhua held 2,843,000 shares, accounting for 0.9282% of the company's total equity [2]. Group 2: Implementation Results of the Reduction Plan - The reduction plan was disclosed on August 7, 2025, with Wang Jianhua planning to reduce up to 710,750 shares, representing 25% of his holdings and 0.2321% of the total equity, between August 12 and November 11, 2025 [2]. - Wang Jianhua successfully reduced 710,700 shares during the specified period, which is 0.2320% of the total equity, aligning with the previously disclosed reduction plan [2][3]. - The actual reduction met the minimum reduction quantity as per the plan, and there was no early termination of the reduction plan [3].
苏州麦迪斯顿医疗科技股份有限公司股东减持股份结果公告